PTC Therapeutics Shares Outstanding 2012-2018 | PTCT

PTC Therapeutics shares outstanding history from 2012 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • PTC Therapeutics shares outstanding for the quarter ending June 30, 2018 were 0.046B, a 16.45% increase year-over-year.
  • PTC Therapeutics 2017 shares outstanding were 0.039B, a 15.09% increase from 2016.
  • PTC Therapeutics 2016 shares outstanding were 0.034B, a 1.25% increase from 2015.
  • PTC Therapeutics 2015 shares outstanding were 0.034B, a 6.53% increase from 2014.
PTC Therapeutics Annual Shares Outstanding
(Millions of Shares)
2017 39
2016 34
2015 34
2014 32
2013 13
2012 0
2011 0
PTC Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 46
Q1 2018 42
Q4 2017 39
Q3 2017 41
Q2 2017 40
Q1 2017 34
Q4 2016 34
Q3 2016 34
Q2 2016 34
Q1 2016 34
Q4 2015 34
Q3 2015 34
Q2 2015 34
Q1 2015 33
Q4 2014 32
Q3 2014 29
Q2 2014 29
Q1 2014 24
Q4 2013 13
Q3 2013 24
Q2 2013 3
Q1 2013 0
Q4 2012 0
Q3 2012 0
Q2 2012 0
Q1 2012 0
Q4 2011 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.975B $0.194B
PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.794B 11.40
Zoetis (ZTS) United States $44.246B 32.11
Tilray (TLRY) United States $14.207B 0.00
Grifols (GRFS) Spain $13.773B 16.81
Neurocrine Biosciences (NBIX) United States $10.366B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.424B 13.87
Nektar Therapeutics (NKTR) United States $8.548B 9.99
Ionis Pharmaceuticals (IONS) United States $6.363B 0.00
Catalent (CTLT) United States $6.119B 26.34
Sage Therapeutics (SAGE) United States $5.778B 0.00
Impax Laboratories (AMRX) United States $5.525B 29.38
United Therapeutics (UTHR) United States $5.482B 7.04
Loxo Oncology (LOXO) United States $5.104B 0.00
FibroGen (FGEN) United States $4.607B 0.00
Endo (ENDP) Ireland $3.928B 5.64
Taro Pharmaceutical Industries (TARO) Israel $3.721B 14.41
Madrigal Pharmaceuticals (MDGL) United States $3.058B 0.00
Aerie Pharmaceuticals (AERI) United States $2.634B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.627B 0.00
USANA Health Sciences (USNA) United States $2.523B 22.22
TESARO (TSRO) United States $2.360B 0.00
Heron Therapeutics (HRTX) United States $2.280B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.975B 0.00
Xencor (XNCR) United States $1.963B 0.00
Endocyte (ECYT) United States $1.646B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.614B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.528B 18.68
Portola Pharmaceuticals (PTLA) United States $1.484B 0.00
Zogenix (ZGNX) United States $1.481B 0.00
Corcept Therapeutics (CORT) United States $1.455B 22.39
Spectrum Pharmaceuticals (SPPI) United States $1.419B 0.00
Esperion Therapeutics (ESPR) United States $1.293B 0.00
TherapeuticsMD (TXMD) United States $1.287B 0.00
Tricida (TCDA) United States $1.265B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.175B 0.00
ImmunoGen (IMGN) United States $1.161B 0.00
Radius Health (RDUS) United States $0.886B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.788B 0.00
Karyopharm Therapeutics (KPTI) United States $0.758B 0.00
Flexion Therapeutics (FLXN) United States $0.705B 0.00
GlycoMimetics (GLYC) United States $0.614B 0.00
ChemoCentryx (CCXI) United States $0.588B 34.38
Dova Pharmaceuticals (DOVA) United States $0.587B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.562B 0.00
Collegium Pharmaceutical (COLL) United States $0.561B 0.00
Dermira (DERM) United States $0.537B 0.00
ArQule (ARQL) United States $0.511B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.508B 0.00
Akebia Therapeutics (AKBA) United States $0.500B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.485B 0.00
OptiNose (OPTN) United States $0.471B 0.00
Forty Seven (FTSV) United States $0.453B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.449B 30.65
Corbus Pharmaceuticals Holdings (CRBP) United States $0.446B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.446B 0.00
Xeris Pharmaceuticals (XERS) United States $0.431B 0.00
Odonate Therapeutics (ODT) United States $0.422B 0.00
Minerva Neurosciences (NERV) United States $0.416B 0.00
Siga Technologies (SIGA) United States $0.405B 0.00
Aquestive Therapeutics (AQST) United States $0.387B 0.00
Depomed (ASRT) United States $0.378B 0.00
Zafgen (ZFGN) United States $0.377B 0.00
Aclaris Therapeutics (ACRS) United States $0.377B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.365B 0.00
Concert Pharmaceuticals (CNCE) United States $0.357B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.355B 0.00
Mast Therapeutics (SVRA) United States $0.351B 0.00
ElectroCore (ECOR) United States $0.345B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.344B 0.00
KalVista Pharmaceuticals (KALV) United States $0.340B 0.00
Translate Bio (TBIO) United States $0.314B 0.00
MEI Pharma (MEIP) United States $0.286B 0.00
CASI Pharmaceuticals (CASI) United States $0.284B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.279B 0.00
Aldeyra Therapeutics (ALDX) United States $0.261B 0.00
Majesco Entertainment (PTE) United States $0.260B 0.00
Aratana Therapeutics (PETX) United States $0.257B 0.00
Tyme Technologies (TYME) United States $0.253B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.251B 0.00
Ardelyx (ARDX) United States $0.243B 0.00
IMV INC (IMV) Canada $0.241B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.239B 0.00
Neon Therapeutics (NTGN) United States $0.235B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.231B 0.00
Opexa Therapeutics (ACER) United States $0.230B 0.00
Melinta Therapeutics (MLNT) United States $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
Affimed (AFMD) Germany $0.203B 0.00
Calithera Biosciences (CALA) United States $0.198B 0.00
Jounce Therapeutics (JNCE) United States $0.190B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.189B 0.00
Redhill Biopharma (RDHL) Israel $0.180B 0.00
Molecular Templates (MTEM) United States $0.180B 0.00
Achaogen (AKAO) United States $0.178B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.174B 0.00
DURECT (DRRX) United States $0.165B 0.00
MediWound (MDWD) Israel $0.163B 0.00
Nature's Sunshine Products (NATR) United States $0.156B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.155B 0.00
ContraFect (CFRX) United States $0.155B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.154B 0.00
India Globalization Capital (IGC) United States $0.152B 0.00
Lannett Co Inc (LCI) United States $0.151B 1.25
Recro Pharma (REPH) United States $0.149B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.148B 0.00
Adherex Technologies (FENC) United States $0.145B 0.00
Infinity Pharmaceuticals (INFI) United States $0.144B 0.00
ProNAi Therapeutics (SRRA) Canada $0.143B 0.00
Champions Oncology (CSBR) United States $0.143B 0.00
BioLineRx (BLRX) Israel $0.132B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.129B 0.00
Neos Therapeutics (NEOS) United States $0.120B 0.00
Cardiome Pharma (CORV) Canada $0.119B 0.00
CTI BioPharma (CTIC) United States $0.115B 0.00
Rafael Holdings (RFL) United States $0.109B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.100B 0.00
Forward Pharma (FWP) Denmark $0.099B 0.00
ENTASIS THERAPT (ETTX) United States $0.097B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.081B 0.00
Immune Design (IMDZ) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Natural Alternatives (NAII) United States $0.073B 8.14
Nivalis Therapeutics (ALPN) United States $0.072B 0.00
Novan (NOVN) United States $0.067B 0.00
Genocea Biosciences (GNCA) United States $0.064B 0.00
Trillium Therapeutics (TRIL) Canada $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 40.48
SCYNEXIS (SCYX) United States $0.049B 0.00
Mannatechorporated (MTEX) United States $0.047B 24.99
Ampio Pharmaceuticals (AMPE) United States $0.045B 0.00
Capnia (SLNO) United States $0.042B 0.00
Heat Biologics (HTBX) United States $0.041B 0.00
Avenue Therapeutics (ATXI) United States $0.040B 0.00
KemPharm (KMPH) United States $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
XTL Biopharmaceuticals (XTLB) Israel $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.033B 0.00
IsoRay (ISR) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.031B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 9.25
HANCOCK JAFFE (HJLI) United States $0.025B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.020B 0.00
NanoViricides (NNVC) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Aradigm (ARDM) United States $0.018B 0.00
Shineco (TYHT) China $0.018B 1.81
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Midatech Pharma (MTP) United Kingdom $0.016B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.014B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Pain Therapeutics (PTIE) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
PharmAthene (ALT) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00